Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women

Gynecologic and Obstetric Investigation

Volumn 62, Issue 3, 2006, Pages 173-180

  Kliucinskas, Mindaugas ^a   Nadisauskiene, Ruta J ^a   Minkauskiene, Meile ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Epidemiology of hpv infection; High risk hpv infection; Risk factors of hpv infection

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONSULTATION; CONTROLLED STUDY; DNA DETERMINATION; EDUCATION; FEMALE; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; LITHUANIA; MAJOR CLINICAL STUDY; MOLECULAR HYBRIDIZATION; ONCOVIRINAE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; SEXUAL BEHAVIOR; SOCIAL ASPECT; SQUAMOUS EPITHELIUM; STATISTICAL ANALYSIS; URBAN POPULATION; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; ALPHAPAPILLOMAVIRUS; COHORT STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; LITHUANIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION; SEXUAL PARTNERS; SMOKING; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 33749186928     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093572     Document Type: Article

References (32)

1. Parkin MD: Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.
2. Aleknaviciene B, Smailyte G, El-Aawar B, et al: Cervical cancer: recent trends of incidence and mortality in Lithuania. Medicina 2002;38:223-230.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC: Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 2001;285:3107-3115.
5. Sonnex C: Human papillomavirus infection with particular reference to genital disease. J Clin Pathol 1998;51:643-648.
6. Castellsague X, Bosch FX, Munoz N: Environmental co-factors in HPV carcinogenesis. Virus Res 2002;89:191-199.
7. Tashakkori A, Teddlie C: Mixed Methodology: Combining Qualitative and Quantitative Approaches. Applied Social Research Methods. Thousands Oaks, Sage Publications, 1998, vol 46.
8. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys Study Group: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-998.
9. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JLN, Ortega L, de Galaz EMB, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K: Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10:1129-1136.
10. Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF: Determinants of cervical human papillomavirus infection: differences between high- and low-risk types. J Infect Dis 2002;185:28-35.
11. Ishi K, Suzuki F, Saito A, Kubota T: Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan. J Obstet Gynaecol Res 2000;26:253-257.
12. Centurioni MG, Puppo A, Merlo DF, Cusimano GR, Sirito R, Gustavino CA: Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis 2005;5:77.
13. Si-Mohamed A, Ndjoyi-Mbiguino A, Cuschieri K, Onas IN, Colombet I, Ozouaki F, Goff JL, Cubie H, Belec L: High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon. J Med Virol 2005;77:430-438.
14. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M: Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-420.
15. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-474.
16. Karlsson R, Jonsson M, Edlund K, et al: Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995;22:119-127.
17. Reed BD, Zazove P, Gregoire L, Gorenflo DW, Lancaster WD, Ruffin MT 4th, Hruzczyk J: Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch Fam Med 1993;2:1239-1248.
18. Kalediene R, Petrauskiene J, Rimpela A: Siuolaikinio visuomenes sveikatos mokslo teorija ir praktika. Kaunas, Sviesa, 1999.
19. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE: Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997;89:868-873.
20. Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Assche FA: Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995;39:34-38.
21. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J: Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000;83:1565-1572.
22. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M: HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-1226.
23. Kruger-Kjaer S, Van Den Brule AJ, Svare EI, Engholm G, Sherman ME, Poll PA, Walboomers JM, Bock JE, Meijer CJ: Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer 1998;76:613-619.
24. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH: Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-341.
25. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzneim R: University students' knowledge and awareness of HPV. Prev Med 1999;28:535-541.
26. Nonnenmacher B, Breitenbach V, Villa LL, Prolla JC, Bozzetti MC: Genital human papillomavirus infection identification by molecular biology among asymptomatic women (in Portuguese). Rev Saude Publica 2002;36:95-100.
27. Jeng CJ, Phdl, Ko ML, Ling QD, Shen J, Lin HW, Tzeng CR, Ho CM, Chien TY, Chen SC: Prevalence of cervical human papillomavirus in Taiwanese women. Clin Invest Med 2005;28:261-266.
28. Reich O: Is early first intercourse a risk factor for cervical cancer? Gynäkol Geburtshilfliche Rundsch 2005;45:251-256.
29. Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pukkinen J, Saarikoski S, Syrjanen K: Prevalence and risk factors of genital human papillomavirus infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993;20:321-328.
30. Thomas DJ: Sexually transmitted viral infections: epidemiology and treatment. J Obstet Gynecol Neonatal Nurs 2001;30:316-323.
31. Gopalkrishna V, Murthy NS, Sharma JK, Roy M, Das DK, Luthra UK, Das BC: Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J Infect Dis 1995;171:254-255.
32. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, de Barahona O, Melchers WJ: Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras. Int J Epidemiol 2000;29:817-825.